The recognition and diagnosis of coeliac disease
| Status: |
History |
| Publication date: |
May 2009 |
| Wave: |
17 |
| Topic area:
|
NICE project team
| Centre for clinical practice lead: |
Fergus Macbeth
|
| Communications manager: |
Kristin O'Leary
|
| Guidelines commissioning manager: |
Nicole Elliot
|
| Guidelines coordinator: |
Emma Banks
|
| Patient involvement lead: |
Barbara Meredith
|
| Implementation lead: |
Clara Loveman
|
| Guidelines Development Group: |
The Guideline Development Group (GDG) oversees the development process.
|
Email enquiries
Provisional schedule
| Consultation on draft scope with stakeholders: |
18 June - 16 July 2008
|
| Scoping workshop: |
05 June 2008 |
| Consultation on draft guideline with stakeholders: |
15 January - 12 February 2009
|
| Pre-publication check: |
TBC |
| Publication date: |
May 2009 |
Project history
| Date |
Update |
| 19 October 2007 |
The remit was received from the Department of Health and the Welsh Assembly Government in April as part of the Institute's 17th wave work programme. |
| 18 June 2008 |
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed below, by the deadline shown. |
| 16 July 2008 |
Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply |
| 28 August 2008 |
The scope defines what aspect of care are covered by the guideline and to whom it applies.
Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.
The Guideline Development Group (GDG) oversees the development process See below for a list of GDG members.
The Short Clinical Guidelines Technical Team (SCGTT) may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The SCGTT will approach all registered stakeholders for this evidence. The SCGTT may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the SCGTT will accept relevant confidential data for consideration by the GDG.
|
| 3 October 2008 |
Development of the clinical guideline is under way and is being led by the Short Clinical Guidelines technical team. Short Clinical Guidelines technical team meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Please see timescales above for dates of consultation with stakeholders. |
| 15 January 2009 |
The consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown. |
| 14 April 2009 |
Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received |
|
Key documents
|
|
|
This page was last updated: 08 May 2009 |
